Biotech · Private company
Calimmune, Inc.
Track this companyFree. Adds Calimmune, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- BusulfanPhase 2 · Human Immunodeficiency VirusClinicalTrials.gov · fetched Nov 12, 2026
- Cal-1 modified CD4+ T lymphocytesPhase 2 · Human Immunodeficiency VirusClinicalTrials.gov · fetched Nov 12, 2026
- Cal-1 modified HSPCPhase 2 · Human Immunodeficiency VirusClinicalTrials.gov · fetched Nov 12, 2026
- Blood testsHIV-1 InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 RecipientsACTIVE_NOT_RECRUITING · started Apr 1, 2015ClinicalTrials.gov NCT02390297 · fetched Nov 12, 2026
- Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 InfectionPHASE1_PHASE2 · COMPLETED · started Apr 1, 2013ClinicalTrials.gov NCT01734850 · fetched Nov 12, 2026